Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $313,751 - $516,491
3,100 New
3,100 $368,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $2.89 Million - $4.34 Million
-41,600 Reduced 81.73%
9,300 $924,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $4.91 Million - $6.44 Million
50,900 New
50,900 $5.26 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $8.22 Million - $13.5 Million
69,600 New
69,600 $8.23 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $9.61 Million - $17.9 Million
-76,000 Reduced 97.06%
2,300 $396,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $17.7 Million - $28.9 Million
78,300 New
78,300 $19.9 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.